<transcript><audio_6>jumping right on into the first one not wasting anybody's time this is ticker vblt vascular biogenics and that ticker just keeps jumping around so she's getting some aftermarket activity here she had some news come out back to</transcript><caption><image_7>The image is a screenshot of a website called VULT. The website has a white background with black text. At the top of the page, there is a header with the company's logo and contact information. Below the header, there are two tabs - "Volt" and "Business Description". 

On the left side of the image, there has a table with three columns. The first column is titled "Financial Reporting" and has a list of financial reporting options. The second column has a description of the company and a brief description of its business.

In the bottom right corner of the screenshot, there appears to be an old-fashioned television set with a man on the screen. The man is wearing a blue hat and a white beard. He is smiling and looking at the camera.</caption><transcript><audio_8>beginning of February she got into a merger deal and they tell us it is supposed to close at any time and her chart is looking sweet now it's been riding on the 200-day for a while there was the occasional punch through that</transcript><transcript><audio_9>looked strong but it came right back down just as quick as it went up but these last few days she has been climbing she's growing and the volume is starting to accumulate so vblt she finished the day-to-day at just about 21</transcript><transcript><audio_10>and a half cents in just over eight percent gains and this is a penny stock on the NASDAQ so what is vascular biogenics about well they tell us one of their news presses that vbl is developing targeted therapies for immune</transcript> jumping right on into the first one not wasting anybody's time this is ticker vblt vascular biogenics and that ticker just keeps jumping around so she's getting some aftermarket activity here she had some news come out back to beginning of February she got into a merger deal and they tell us it is supposed to close at any time and her chart is looking sweet now it's been riding on the 200-day for a while there was the occasional punch through that looked strong but it came right back down just as quick as it went up but these last few days she has been climbing she's growing and the volume is starting to accumulate so vblt she finished the day-to-day at just about 21 and a half cents in just over eight percent gains and this is a penny stock on the NASDAQ so what is vascular biogenics about well they tell us one of their news presses that vbl is developing targeted therapies for immune
{"source": "grass-yt-cc-by.13rItc4lCUg|shard_10047_56|create_multimodal_data.extract_yt_and_generate_transcripts.28|shard_10047|create_multimodal_data.generate_captions.28|shard_10047|create_multimodal_data.generate_captions.28", "params": {"id": "13rItc4lCUg", "channel_id": "UCVJ2W5b6x-qEKbnsYFgoHtA", "duration": 713, "view_count": 250, "age_limit": 0, "chapters": [{"start_time": 0.0, "title": "Intro", "end_time": 65.0}, {"start_time": 65.0, "title": "VBLT", "end_time": 438.0}, {"start_time": 438.0, "title": "VBLT Chart", "end_time": 691.0}, {"start_time": 691.0, "title": "Outro", "end_time": 713}], "like_count": 21, "channel_follower_count": 4770, "license": "Creative Commons Attribution license (reuse allowed)", "uploader_id": "@stockswizard8888", "yt_tar_file": "/leonardo_work/EUHPC_E03_068/audio/fixed_download/grass-yt-cc-by//shard_10047/13rItc4lCUg.tar.gz"}}